伏立康唑
医学
伊曲康唑
泊沙康唑
三级转诊医院
两性霉素B
药物警戒
组织病理学
芹茎孢
抗真菌
外科
米卡芬金
不利影响
介绍
皮肤病科
阿米西达
大学医院
罪魁祸首
作者
Zhi‐min Hu,Wei He,Bin Hu,Liang Zou,Liu-Qing Chen
标识
DOI:10.1111/1346-8138.70366
摘要
Purpureocillium lilacinum, a saprobic filamentous fungus with a global distribution, is an emerging opportunistic pathogen, but its clinical and microbiological profile in China is not well characterized. This study retrospectively analyzed three cases of Purpureocillium lilacinum hyalohyphomycosis in central China and reviewed 7 additional cases from mainland China (2010-2025). The diagnosis was made through a meticulous integration of histopathological analysis, cultivation characteristics, Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS), and internal transcribed spacer (ITS) sequencing. All isolates had high minimum inhibitory concentrations (MICs) to amphotericin B, echinocandins, and fluconazole. Voriconazole and posaconazole showed the highest in vitro activity (MICs 0.12-1 mg/L and 0.25-0.5 mg/L, respectively), while itraconazole susceptibility varied (MIC 0.5-4 mg/L). Rapid and accurate identification requires confirmation via histopathology combined with MALDI-TOF MS or molecular diagnostic methods. Successful management relies on early suspicion, susceptibility-guided therapy with voriconazole and posaconazole, and surgical intervention when appropriate.
科研通智能强力驱动
Strongly Powered by AbleSci AI